HRT Financial’s Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share GRND.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,378
Closed -$43K 3454
2024
Q3
$43K Sell
14,378
-6,053
-30% -$18.4K ﹤0.01% 2126
2024
Q2
$66K Hold
20,431
﹤0.01% 1807
2024
Q1
$47K Hold
20,431
﹤0.01% 1939
2023
Q4
$36K Sell
20,431
-989
-5% -$1.2K ﹤0.01% 1987
2023
Q3
$16K Buy
21,420
+1,089
+5% +$820 ﹤0.01% 2085
2023
Q2
$14K Sell
20,331
-100
-0.5% -$75 ﹤0.01% 2143
2023
Q1
$18K Hold
20,431
﹤0.01% 2195
2022
Q4
$9K Buy
+20,431
New +$12.1K ﹤0.01% 2233

Other funds holding GRND.WS

HRT Financial's GRND.WS Position: Q4 2024 in Review

HRT Financial sold out of Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (GRND.WS) in Q4 2024, closing a stake of 14,378 shares — an estimated $43K sold.

HRT Financial first reported a position in GRND.WS in Q4 2022 and held it in 8 quarters. The position peaked at $66K in Q2 2024. 17 funds tracked by Wall St. Rank hold GRND.WS as of Q4 2024.

  • HRT Financial reported no remaining Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 14,378 Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2024, an estimated $43K.
  • HRT Financial first reported a position in Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2022 and held it in 8 quarters.
  • HRT Financial's Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $66K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.